Experimental immune therapy generally safe, well-tolerated in women with triple-negat

[News]

Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.

More... (http://www.news-medical.net/news/20150421/Experimental-immune-therapy-generally-safe-well-tolerated-in-women-with-triple-negative-breast-cancer.aspx)